Unexplored therapeutic opportunities in the human genome.
Unexplored therapeutic opportunities in the human genome.
复制标题
DOI:
10.1038/nrd.2018.14
复制
发表时间:
2018-05
期刊:
影响因子:
--
通讯作者:
Zahoránszky-Köhalmi G
中科院分区:
文献类型:
--
作者:
Oprea TI;Bologa CG;Brunak S;Campbell A;Gan GN;Gaulton A;Gomez SM;Guha R;Hersey A;Holmes J;Jadhav A;Jensen LJ;Johnson GL;Karlson A;Leach AR;Ma'ayan A;Malovannaya A;Mani S;Mathias SL;McManus MT;Meehan TF;von Mering C;Muthas D;Nguyen DT;Overington JP;Papadatos G;Qin J;Reich C;Roth BL;Schürer SC;Simeonov A;Sklar LA;Southall N;Tomita S;Tudose I;Ursu O;Vidovic D;Waller A;Westergaard D;Yang JJ;Zahoránszky-Köhalmi G
A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied, but potentially druggable, proteins, the US National Institutes of Health launched the Illuminating the Druggable Genome (IDG) initiative in 2014. In this article, we discuss how the systematic collection and processing of a wide array of genomic, proteomic, chemical and disease-related resource data by the IDG Knowledge Management Center have enabled the development of evidence-based criteria for tracking the target development level (TDL) of human proteins, which indicates a substantial knowledge deficit for approximately one out of three proteins in the human proteome. We then present spotlights on the TDL categories as well as key drug target classes, including G protein-coupled receptors, protein kinases and ion channels, which illustrate the nature of the unexplored opportunities for biomedical research and therapeutic development.
登录
查看更多内容
影响因子:
64.8
作者:
GTEx Consortium;Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group;Statistical Methods groups—Analysis Working Group;Enhancing GTEx (eGTEx) groups;NIH Common Fund;NIH/NCI;NIH/NHGRI;NIH/NIMH;NIH/NIDA;Biospecimen Collection Source Site—NDRI;Biospecimen Collection Source Site—RPCI;Biospecimen Core Resource—VARI;Brain Bank Repository—University of Miami Brain Endowment Bank;Leidos Biomedical—Project Management;ELSI Study;Genome Browser Data Integration &Visualization—EBI;Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz;Lead analysts:;Laboratory, Data Analysis &Coordinating Center (LDACC):;NIH program management:;Biospecimen collection:;Pathology:;eQTL manuscript working group:;Battle A;Brown CD;Engelhardt BE;Montgomery SB
通讯作者:
Montgomery SB
影响因子:
14.9
作者:
Nguyen DT;Mathias S;Bologa C;Brunak S;Fernandez N;Gaulton A;Hersey A;Holmes J;Jensen LJ;Karlsson A;Liu G;Ma'ayan A;Mandava G;Mani S;Mehta S;Overington J;Patel J;Rouillard AD;Schürer S;Sheils T;Simeonov A;Sklar LA;Southall N;Ursu O;Vidovic D;Waller A;Yang J;Jadhav A;Oprea TI;Guha R
通讯作者:
Guha R
影响因子:
7.7
作者:
Gloyn, AL;Weedon, MN;Frayling, TM
通讯作者:
Frayling, TM
影响因子:
56.9
作者:
Campillos, Monica;Kuhn, Michael;Bork, Peer
通讯作者:
Bork, Peer
影响因子:
10.6
作者:
Berman, RM;Cappiello, A;Krystal, JH
通讯作者:
Krystal, JH